Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2025-12-24 @ 5:20 PM
NCT ID:
NCT05437250
Eligibility Criteria:
Inclusion Criteria:
* Male or female patients aged ≥ 18 years old,
* CLL patients initiated with acalabrutinib at their physician's discretion between January 1st 2021 and December 31st 2022,
* Patients alive at study initiation and who have been informed verbally and/or in writing about this study, and who do not object to their data being electronically processed or subjected to data quality control (certified by physician); or patient who died before study initiation and who did not object to data collection for research purpose(s) during his or her lifetime.
Exclusion Criteria:
* Patients participating in a clinical trial with an investigational drug within 30 days prior to acalabrutinib initiation,
* Patients who initiated acalabrutinib treatment before January 1st 2021.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05437250
Study Brief:
Protocol Section:
NCT05437250